Clinuvel Pharmaceuticals Ltd Is A Global Specialty Pharmaceutical Company Based In Melbourneaustraliathecompany Focuses On Developing And Commercializing Treatments For Geneticmetabolicsystemicand Lifethreatening Acutedisorderswith Operations In Europetheusisraeland Australiaclinuvel Aims To Address Unmet Medical Needs Through Innovativehealthcaresolutions Thecompany Offers Several Productsincluding Scenessea A Drug Approved For Preventing Phototoxicity In Adults With Erythropoietic Protoporphyriaepp Other Products In Development Includepra Numbraa A Liquid Formulation For Acutedisordersand Neuracthelainstanttargeting Neurological And Metabolic Conditionsin 202 Clinuvel Launched Cyacaslleits First Photocosmetic Product For Photoprotectionthecompany Serves Adult Epp Patients And Broader Populations Needing Dna Repair And Acutecareemphasizing Partnerships With Healthcareproviders And At Risk Individualsclinuvel Is Committed To Ethical Practicesemployeedevelopmentand Environmental Responsibilitywith A Strong Focus On Research And Development In Melanocortins And Photoprotection
